0 Yorumlar
0 Paylaşımlar
169 Görüntülenme
0 İncelemeler
Ara
Yeni insanlar keşfedin, yeni bağlantılar kurun ve yeni arkadaşlar edinin
👥
0
🟢
0
-
Beğenmek, paylaşmak ve yorum yapmak için lütfen giriş yapın!
-
Advancements in Gene Therapy Driving the Hemophilia Treatment MarketThe Hemophilia Treatment Market is at the cusp of a transformative era, with significant trends poised to redefine its future. With a projected market size of USD 19.6 billion by 2035, the sector is expected to grow at a CAGR of 4.25% from an estimated USD 12.4 billion in 2024. Innovations in treatment modalities and patient management strategies are driving this promising growth. A detailed...0 Yorumlar 0 Paylaşımlar 29 Görüntülenme 0 İncelemeler
-
AI and Gene Editing Technologies Strengthen Global T-Cell Therapy Industry GrowthT-Cell Therapy Market Expands Rapidly as Advanced Cell-Based Immunotherapies Transform Cancer Treatment Overview The Global T-Cell Therapy Market is witnessing remarkable growth as biotechnology companies, pharmaceutical manufacturers, and healthcare institutions increasingly invest in advanced cell-based immunotherapies for cancer treatment and immune-related diseases. T-cell therapy has...0 Yorumlar 0 Paylaşımlar 107 Görüntülenme 0 İncelemeler
-
Alpha Thalassemia Market: How Is Gene Therapy Positioning Itself as a Curative Solution?Gene therapy's application to alpha thalassemia — the lentiviral vector and CRISPR-based approaches targeting the HBA1 and HBA2 globin gene defects underlying hemoglobin H disease and the potentially lethal Bart's hydrops fetalis representing the most transformative development in thalassemia medicine, with the Alpha Thalassemia Market increasingly defined by the curative promise of gene...0 Yorumlar 0 Paylaşımlar 116 Görüntülenme 0 İncelemeler
-
Arginase Deficiency Therapeutics Market — Gene Therapy and Enzyme Replacement Innovations Redefining a Rare Urea Cycle DisorderArginase deficiency — a rare autosomal recessive urea cycle disorder (UCD) in which a genetic deficiency of the arginase-1 enzyme causes toxic accumulation of arginine and ammonia in the blood — affects an estimated 1 in 300,000 to 1,000,000 individuals globally. Despite its rarity, the clinical consequences of untreated arginase deficiency are severe and progressive: intellectual...0 Yorumlar 0 Paylaşımlar 25 Görüntülenme 0 İncelemeler
-
Biobanking Market: How Is the Cell and Gene Therapy Pipeline Transforming Biobanking Requirements?Cell and gene therapy's biobanking revolution — the requirement for long-term cryogenic preservation of autologous patient cells (leukapheresis products for CAR-T manufacturing), allogeneic starting materials (iPSC-derived cell therapy banks, NK cell banks), viral vectors (AAV and lentiviral vector GMP banks), and clinical trial reference samples creating a new class of high-value,...0 Yorumlar 0 Paylaşımlar 122 Görüntülenme 0 İncelemeler
-
Cell & Gene Therapy Market: Regional Growth AnalysisThe landscape of modern medicine is shifting. We are moving away from the era of "treating symptoms" and entering a definitive age of "curing causes." At the heart of this revolution is the Cell & Gene Therapy Market, a sector that isn’t just growing, it's fundamentally rewriting the healthcare playbook. The global Cell & Gene Therapy market was valued at USD...0 Yorumlar 0 Paylaşımlar 224 Görüntülenme 0 İncelemeler
-
Cell And Gene Therapy Bioassay Services Market: How Is Immunogenicity Assessment Creating Advanced Service Innovation?Immunogenicity assessment creating service innovation — the growing recognition that cell and gene therapy immunogenicity — host immune responses to therapeutic cells, viral vectors, and transgene products — represents a critical safety and efficacy attribute requiring specialized bioassay services for pre-clinical assessment, manufacturing surveillance, and clinical...0 Yorumlar 0 Paylaşımlar 55 Görüntülenme 0 İncelemeler
-
Cell and Gene Therapy Manufacturing Market to 2036 | USD 336.2B Growth at 23.8% CAGRThe global Cell and Gene Therapy Manufacturing Market is witnessing exponential growth, with market value estimated at USD 39.76 billion in 2026 and projected to reach USD 336.25 billion by 2036, growing at a CAGR of 23.8% during the forecast period. Increasing adoption of personalized medicine, expanding clinical pipelines for gene and cell therapies, and rising investments in viral vector...0 Yorumlar 0 Paylaşımlar 96 Görüntülenme 0 İncelemeler
-
Cell And Gene Therapy Solutions Market: How Is CAR-T Manufacturing Creating Commercial Cell Therapy Infrastructure?CAR-T manufacturing creating infrastructure — cell and gene therapy solutions market's emergence as comprehensive ecosystem providing CAR-T cell manufacturing, gene therapy manufacturing, clinical development support, and therapeutic delivery platforms — establishing integrated solutions providers consolidating manufacturing complexity enabling therapeutic developers to focus on...0 Yorumlar 0 Paylaşımlar 43 Görüntülenme 0 İncelemeler
-
Antisense Therapy Market Future Growth PotentialThe antisense therapy sector is emerging as a transformative segment within nucleic acid-based therapeutics, driven by advancements in genetic research, increasing prevalence of rare and chronic diseases, and rising demand for precision medicine. Antisense oligonucleotide technologies are gaining strong clinical acceptance due to their ability to selectively target disease-causing mRNA...0 Yorumlar 0 Paylaşımlar 166 Görüntülenme 0 İncelemeler
-
Biologics Drug Development Trends Create Strong CRO DemandThe biologics contract research organizations market is witnessing strong expansion as pharmaceutical and biopharmaceutical companies increasingly rely on specialized research partners to accelerate drug development and improve operational efficiency. The global biologics contract research organizations market size was estimated at USD 14.88 billion in 2025 and is projected to reach USD 32.30...0 Yorumlar 0 Paylaşımlar 186 Görüntülenme 0 İncelemeler
-
Bioprocess Containers Market to Hit USD 4.18 Billion by 2032“According to a new report published by Introspective Market Research, the Bioprocess Containers Market by Product Type, Material, and End User, the Global Bioprocess Containers Market Size was Valued at USD 2.14 Billion in 2023 and is Projected to Reach USD 4.18 Billion by 2032, Growing at a CAGR of 12.2%.” The bioprocess containers market plays a vital role in modern...0 Yorumlar 0 Paylaşımlar 761 Görüntülenme 0 İncelemeler
-
CDMO Market Growth Driven by Biologics and Advanced TherapiesEvolving Landscape of Cell & Gene Therapy CDMOs The global cell and gene therapy CDMO market is undergoing rapid transformation, driven by the increasing complexity of advanced therapeutics and the growing reliance on outsourcing. A biopharmaceutical CDMO today is no longer limited to traditional manufacturing; it has evolved into a strategic partner offering end-to-end CDMO services, from...0 Yorumlar 0 Paylaşımlar 343 Görüntülenme 0 İncelemeler
-
Gene Therapy In CNS Disorder Market: How Is Neurodegenerative Disease Burden Creating Therapeutic Opportunity?Neurodegenerative disease burden creating opportunity — neurodegenerative diseases (Spinal Muscular Atrophy, Parkinson's disease, Alzheimer's disease, ALS) affecting millions with devastating progressive neurological decline and limited disease-modifying treatments — establishing compelling therapeutic need where gene therapy's potential to restore neuronal function or prevent...0 Yorumlar 0 Paylaşımlar 41 Görüntülenme 0 İncelemeler
-
Gene Therapy Market Growth Accelerates: Trends, Opportunities, and Forecast 2025–2031According to the report, the Gene Therapy Market is projected to reach US$ 12.92 billion by 2031 from US$ 5.06 billion in 2024, registering a CAGR of 14.50% during 2025–2031. This strong growth trajectory reflects the rising adoption of innovative therapies aimed at treating genetic disorders, cancers, and rare diseases at their root cause. The global Gene Therapy Market Growth is...0 Yorumlar 0 Paylaşımlar 121 Görüntülenme 0 İncelemeler
Daha Fazla Sonuç